XT
EFTR

XTX Topco’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

XTX Topco’s Portfolio EFTR Stock Details EFTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,153
Closed -$23.9K – 2129
2023
Q2 		$23.9K Buy
+1,153
New +$19.5K ﹤0.01% 1306

Other funds holding EFTR

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SOA
Sea Otter Advisors Miami, Florida $1.78M AUM 2.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco's EFTR Position: Q3 2023 in Review

XTX Topco sold out of eFFECTOR Therapeutics, Inc. Common Stock (EFTR) in Q3 2023, closing a stake of 1,153 shares — an estimated $23.9K sold.

XTX Topco first reported a position in EFTR in Q2 2023 and held it in 1 quarter. The position peaked at $23.9K in Q2 2023. 29 funds tracked by Wall St. Rank hold EFTR as of Q3 2023.

  • XTX Topco reported no remaining eFFECTOR Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • XTX Topco sold 1,153 eFFECTOR Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $23.9K.
  • XTX Topco first reported a position in eFFECTOR Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • XTX Topco's eFFECTOR Therapeutics, Inc. Common Stock position peaked at $23.9K in Q2 2023.
  • 29 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Common Stock as of Q3 2023.

Based on XTX Topco's 13F filing for Q3 2023, filed 13 Nov 2023.